CSNK1A1 and neoplasm: Furthermore, inhibition of CK1 isoforms, or RNAi-mediated silencing of CSNK1A1, sensitises tumour cells to TNF-related Apoptosis-inducing Ligand (TRAIL)-induced apoptosis [126].